Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 15,758 | 3,227 | 7,404 | 3,119 | 3,525 |
| Operating Income | -15,758 | -3,227 | -7,404 | -3,119 | -3,525 |
| Interest Expense | 61 | 723 | 121 | 50 | 55 |
| Other Income | 505 | -1,263 | 37 | 1,274 | -125 |
| Pre-tax Income | -15,314 | -5,213 | -7,488 | -1,895 | -3,705 |
| Income Tax | -859 | 85 | -1,088 | N/A | N/A |
| Net Income Continuous | -14,455 | -5,298 | -6,400 | -1,895 | -3,705 |
| Net Income | $-14,455 | $-5,298 | $-6,400 | $-1,895 | $-3,705 |
| EPS Basic Total Ops | 0.00 | -12.72 | -7.84 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -10.30 | -7.84 | -2.41 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -12.72 | -7.84 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -10.30 | -7.84 | -2.41 | -0.01 |
| EBITDA(a) | $-15,758 | $-3,227 | $-7,404 | $-3,119 | $-3,525 |